Table of Content


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders


2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome


3. Executive Summary
3.1. Market Outlook
3.2. Product Type Outlook
3.3. Application Outlook
3.4. End-User Outlook
3.5. Competitor Outlook


4. Market Overview
4.1. Introduction


5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges


6. United States Blood Transfusion Diagnostics Market, By Product Type
6.1. Introduction
6.2. Instruments and Kits
6.3. Reagents


7. United States Blood Transfusion Diagnostics Market, By Application
7.1. Introduction
7.2. Blood Grouping
7.3. Disease Screening


8. United States Blood Transfusion Diagnostics Market, By End-User
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Hospitals
8.4. Plasma Fractionation Companies


9. 360iResearch Competitive Strategic Window
9.1. Introduction
9.2. 360iResearch Competitive Strategic Window, by Product Type
9.3. 360iResearch Competitive Strategic Window, by Application
9.4. 360iResearch Competitive Strategic Window, by End-User


10. Competitive Landscape
10.1. 360iResearch FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. 360iResearch Market Ranking Analysis
10.3. 360iResearch Market Share Analysis
10.4. 360iResearch Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion


11. Company Usability Profiles
11.1. Abbott Laboratories.
11.2. DiaSorin S.p.A
11.3. F. Hoffmann-La Roche Ltd
11.4. Grifols, S.A.
11.5. Ortho Clinical Diagnostics


12. Appendix
12.1. Discussion Guide
12.2. Edition Details
12.3. License Details
12.4. Pricing Details



List of Figures



FIGURE 1. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 6. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
FIGURE 7. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET, BY TYPE
FIGURE 8. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 10. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 11. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2019 VS 2025 (USD MILLION)
FIGURE 12. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 13. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2025
FIGURE 17. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 18. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS


List of Tables



TABLE 1. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND KITS, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUPING, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DISEASE SCREENING, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PLASMA FRACTIONATION COMPANIES, 2017-2025 (USD MILLION)
TABLE 9. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: SCORES
TABLE 10. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 11. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 12. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: RANKING
TABLE 13. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 14. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 15. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 16. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 17. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 18. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: EDITION DETAILS
TABLE 19. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: LICENSE DETAILS
TABLE 20. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET: PRICING DETAILS